Case 3: Kaposi's Sarcoma

Case-Based Modules
Initial Evaluation
Dermatologic Manifestations
Oral Manifestations
OIs: Prophylaxis
OIs: Treatment
Antiretroviral Rx
Antiretroviral Rx: Resistance
Antiretroviral Rx: Adverse Effects
Drug-Drug Interactions
Postexposure Prophylaxis
Perinatal Transmission
Special Populations
Prevention for Positives
Challenging Unknowns
Interactive Tutorials
This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.

Home
About This Site
Free CME
AETC NRC
Resources
Feedback
Site Map
Authors

Question | Discussion | References | CME Credit

You answered:

	Human herpes virus type 6 (HHV-6) is the causative agent of Kaposi's sarcoma.

This answer is incorrect. Multiple lines of evidence have now established that human herpes virus type 8 (HHV-8), not HHV-6 is the causative agent of Kaposi's sarcoma.

Choose another answer:

	In some patients, highly active antiretroviral therapy alone causes significant improvement of Kaposi's sarcoma lesions.
	Visceral, but not isolated cutaneous Kaposi's sarcoma, is an AIDS-defining illness.
	Liquid nitrogen cryotherapy is generally ineffective for management of localized cutaneous Kaposi's sarcoma lesions.

[Back to Case 3 Question | Go to Correct Answer]